louisiana semaglutide gastric stasis legal team gastrointestinal obstruction FDA updates Ozempic label to acknowledge some users' reports of blocked intestines semaglutide gastric stasis law firm

The manufacturer had no role in study design, data collection, data analysis, or manuscript preparation

However, as with any potent medication, understanding its precise application is paramount

It is yet to be confirmed whether it was the medication itself or the combination of rapid loss of weight, dehydration, lack of movement, or an existing underlying condition that may be more directly responsible for the clotting

[DOI] [PubMed] [Google Scholar] 675

This could lead to situations where patients may also misattribute symptoms to their illicit GLP-1 medication, potentially missing the early diagnosis and treatment of unrelated illnesses, and as a result, poorer health outcomes for patients and increased costs to the NHS